A Promising Step Towards an HIV Cure: Unleashing the Power of Gene-Editing

A Promising Step Towards an HIV Cure: Unleashing the Power of Gene-Editing
Gene-Editing: In Search of HIV Cure

In the ongoing battle against HIV/AIDS, researchers are constantly seeking innovative ways to combat the virus and develop a cure. Recently, a groundbreaking gene-editing strategy has emerged, harnessing the protective abilities of genetic alterations found in MOGS-CDG disorder. Scientists at the Lewis Katz School of Medicine at Temple University have pioneered this novel approach, demonstrating its potential to eliminate HIV-1 infection without harming healthy cells. Let's delve into the fascinating world of gene editing and its potential implications in the quest for an HIV cure.

Understanding MOGS-CDG and Viral Infection:

MOGS-CDG, a rare and fatal disorder, has been at the center of scientific curiosity due to its intriguing paradoxical effects. While it leads to a devastating disorder, it also confers protection against viral infections like HIV, influenza, SARS-CoV-2, and hepatitis C. The key lies in the MOGS gene, which plays a crucial role in glycosylation - a process that modifies cellular proteins to make them stable and functional. Unfortunately, certain viruses exploit this glycosylation process to infiltrate host cells, making MOGS an intriguing target for potential therapeutic interventions.

The Gene-Editing Approach

The researchers at Temple University, led by Dr. Kamel Khalili, Professor Laura H Carnell, and Assistant Professor Rafal Kaminski, designed a unique genetic approach to specifically disrupt the MOGS gene expression through DNA editing. They combined two gene-editing constructs - one targeting the HIV-1 DNA and the other aimed at the MOGS gene. By precisely stimulating this genetic apparatus within HIV-infected immune cells, the team effectively obstructed the glycan structure of the HIV-1 envelope protein, resulting in the production of non-infectious virus particles.

A Conceptually Interesting Breakthrough

Dr. Khalili described the approach as "conceptually very interesting" as it offers an additional target, the MOGS gene, alongside the integrated viral DNA for CRISPR gene-editing technology development. By inhibiting the virus's ability to enter cells through glycosylation, the researchers hope to advance the next generation of CRISPR-based gene-editing technology for HIV eradication.

Promising Path to HIV Cure

This groundbreaking research opens up new avenues in the quest for an HIV cure. By specifically targeting infected cells and impairing the virus's ability to produce infectious particles, the CRISPR-MOGS strategy offers hope for developing a highly effective and safe treatment. Additionally, the approach is designed to avoid adverse effects on healthy cells that retain normal MOGS gene function, further enhancing its therapeutic potential.

Moving Forward: Preclinical Studies and Beyond

The team is collaborating with Professor Tricia H Burdo, an expert in non-human primate models for HIV-1, to assess the efficacy and safety of the CRISPR-MOGS strategy in preclinical studies. Their previous success in removing viral DNA from infected non-human primates using CRISPR-based technology provides a promising foundation for this next step.


As the fight against HIV/AIDS continues, this remarkable gene-editing breakthrough offers new hope and potential in the quest for a cure. By leveraging the protective abilities of MOGS-CDG genetic alterations, scientists are advancing towards a future where HIV-1 infection could be effectively eliminated without harming healthy cells. The journey to an HIV cure is still ongoing, but with each innovative discovery, we move one step closer to a world free from the grip of this devastating disease.


Post a Comment


Post a Comment (0)

#buttons=(Accept !) #days=(20)

Our website uses cookies to enhance your experience. Check Now
Accept !